Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
Author:
Affiliation:
1. School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of XinJiang Bingtuan, Shihezi University, Shihezi, China;
2. XinJiang Huashidan Pharmaceutical Research Co. Ltd., Urumqi, China
Funder
scientific research innovation project
Program for Outstanding Youth Science and Technology Innovation Talents Training
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://tandfonline.com/doi/pdf/10.1080/14756366.2018.1497619
Reference34 articles.
1. Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2. Antitumor agents 201.1 Cytotoxicity of harmine and β-carboline analogs
3. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
4. Design, synthesis and 3D-QSAR of β-carboline derivatives as potent antitumor agents
5. Synthesis and structure–activity relationships of harmine derivatives as potential antitumor agents
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beta-carboline as a promising heterocyclic nucleus: Synthetic aspects, pharmacological potential and structure activity relationship;European Journal of Medicinal Chemistry Reports;2022-12
2. Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives – An Update;Journal of Molecular Structure;2022-08
3. A comprehensive overview of β-carbolines and its derivatives as anticancer agents;European Journal of Medicinal Chemistry;2021-11
4. Bioinspired imidazo[1,2-a:4,5-c’]dipyridines with dual antiproliferative and anti-migrative properties in human cancer cells: The SAR investigation;European Journal of Medicinal Chemistry;2021-06
5. Role of Active Components of Medicinal Food in the Regulation of Angiogenesis;Frontiers in Pharmacology;2021-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3